THERAPEUTIC AGENT

Brand Owner (click to sort) Address Description
ENTERICA CYTOSORBENTS CORPORATION 305 College Road East Princeton NJ 08540 Therapeutic agent, namely, eternally administered therapeutic sorbent in the nature of synthetic, polymeric, or processed natural materials for pharmaceutical purposes designed to reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to reduce both local and systemic inflammation and tissue injury;ENTERIC A;
ENTERICA CYTOSORBENTS CORPORATION 305 College Road East Princeton NJ 08540 Therapeutic agent, namely, chemicals in the nature of internally administered therapeutic sorbent in the nature of synthetic, polymeric, or processed natural materials for pharmaceutical purposes designed to reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to reduce both local and systemic inflammation and tissue injury;
MACROLIN CETUS CORPORATION 600 BANCROFT WAY BERKELEY CA 94710 THERAPEUTIC AGENT, NAMELY MACROPHAGE COLONY STIMULATING FACTOR FOR USE IN TREATMENT OF THE IMMUNE SYSTEM, AS AN ANTI-CANCER AGENT, AN ANTI-INFECTIVE AGENT AND A BLOOD TREATMENT AGENT;
TERRA-PATTIES MANN LAKE, LTD. 501 1st Street South Hackensack MN 56452 therapeutic agent; namely, oxytetra cycline for bees contained in carrier substrate;
TERRA-PATTIES MANN LAKE SUPPLY LTD. County Road 40 & First Street Hackensack MN 56452 therapeutic agent; namely, oxytetra cycline for bees contained in carrier substrate;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula: